Selective muscarinic M1 antagonists: drug design and discovery
- 1 August 1997
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 2 (8) , 341-350
- https://doi.org/10.1016/s1359-6446(97)01076-3
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Immunological localization of m1–m5 muscarinic acetylcholine receptors in peripheral tissues and brainPublished by Elsevier ,2002
- S-(−)-ET 126: A potent and selectivE M1 antagonist in vitro and in vivoLife Sciences, 1996
- 3-Heteroaryl-Substituted Quinuclidin-3-ol and Quinuclidin-2-ene Derivatives as Muscarinic Antagonists. Synthesis and Structure-Activity RelationshipsJournal of Medicinal Chemistry, 1995
- Synthesis, absolute configuration, conformational analysis and binding affinity properties of enantiomeric forms of DAU 5750, a novel M1–M3 muscarinic receptor antagonistBioorganic & Medicinal Chemistry, 1994
- Muscarinic receptor subtypes in airwaysLife Sciences, 1993
- m1-toxinLife Sciences, 1993
- Synthesis and muscarinic cholinergic receptor affinities of 3-quinuclidinyl .alpha.-(alkoxyalkyl)-.alpha.-aryl-.alpha.-hydroxyacetatesJournal of Medicinal Chemistry, 1991
- Muscarinic receptor binding profile of para-substituted caramiphen analogsJournal of Medicinal Chemistry, 1991
- Clinical Significance of M1 Receptor AntagonistsPharmacology, 1988
- Role of the Cholinergic Nervous System in Acid SecretionPharmacology, 1988